Genetically engineered human acetylcholinesterase
US5595903A · kind A · utility
9Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 1993 |
| Grant date | Jan 21, 1997 |
| Priority date | — |
| Expiry date | Aug 2, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered human acetylcholinesterase and antibodies that def the protein are described. These composition may be used in pharmaceutical preparations for treatment and prophylaxis of organo-phosphorous compound poisoning or post-operative apnea. Also described are human cholinesterase DNA probes which may be employed for diagnosing progressing ovarian carcinomas and hemocytopoietic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.